These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 23955767

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antinuclear Antibodies and Lupus-like Manifestations in Rheumatoid Arthritis and Ankylosing Spondylitis Patients at 4 Months' Follow-up After Treatment with Infliximab and Etanercept.
    Aghdashi MA, Khadir M, Dinparasti-Saleh R.
    Curr Rheumatol Rev; 2020; 16(1):61-66. PubMed ID: 31057111
    [Abstract] [Full Text] [Related]

  • 3. Diverse patterns of anti-TNF-α-induced lupus: case series and review of the literature.
    Shovman O, Tamar S, Amital H, Watad A, Shoenfeld Y.
    Clin Rheumatol; 2018 Feb; 37(2):563-568. PubMed ID: 29063464
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.
    Ramos-Casals M, Brito-Zerón P, Muñoz S, Soria N, Galiana D, Bertolaccini L, Cuadrado MJ, Khamashta MA.
    Medicine (Baltimore); 2007 Jul; 86(4):242-251. PubMed ID: 17632266
    [Abstract] [Full Text] [Related]

  • 6. TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists.
    Williams VL, Cohen PR.
    Int J Dermatol; 2011 May; 50(5):619-25. PubMed ID: 21506984
    [Abstract] [Full Text] [Related]

  • 7. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.
    McLeod C, Bagust A, Boland A, Dagenais P, Dickson R, Dundar Y, Hill RA, Jones A, Mujica Mota R, Walley T.
    Health Technol Assess; 2007 Aug; 11(28):1-158, iii-iv. PubMed ID: 17651658
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey.
    De Bandt M, Sibilia J, Le Loët X, Prouzeau S, Fautrel B, Marcelli C, Boucquillard E, Siame JL, Mariette X, Club Rhumatismes et Inflammation.
    Arthritis Res Ther; 2005 Aug; 7(3):R545-51. PubMed ID: 15899041
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis.
    Giardina AR, Ferrante A, Ciccia F, Impastato R, Miceli MC, Principato A, Triolo G.
    Rheumatol Int; 2010 Sep; 30(11):1437-40. PubMed ID: 19851772
    [Abstract] [Full Text] [Related]

  • 12. Tumour necrosis factor inhibitor-related lupus: safety of switching agents.
    Luong JM, Tan BT, Buchanan RR, Schachna L.
    Clin Rheumatol; 2010 May; 29(5):551-3. PubMed ID: 20119843
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anti-TNF-alpha-induced systemic lupus syndrome.
    Debandt M, Vittecoq O, Descamps V, Le Loët X, Meyer O.
    Clin Rheumatol; 2003 Feb; 22(1):56-61. PubMed ID: 12605321
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.